tiprankstipranks
Acura Pharmaceuticals (ACUR)
OTHER OTC:ACUR
US Market

Acura Pharmaceuticals (ACUR) Stock Price & Analysis

77 Followers

ACUR Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.05 - $0.05
Previous Close$0.05
Volume615.00
Average Volume (3M)N/A
Market Cap
$231.01K
Enterprise Value$216.01K
Total Cash (Recent Filing)$65.00K
Total Debt (Recent Filing)$50.00K
Price to Earnings (P/E)N/A
Beta5.19
Nov 14, 2022
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding65,089,043
10 Day Avg. Volume83
30 Day Avg. VolumeN/A
Standard Deviation13.03
R-Squared0.04
Alpha1.55
Financial Highlights & Ratios
Price to Book (P/B)2.78
Price to Sales (P/S)0.10
Price to Cash Flow (P/CF)0.30
P/FCF Ratio0.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.14
Enterprise Value/Gross Profit0.14
Enterprise Value/Ebitda-0.37
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

ACUR FAQ

What was Acura Pharmaceuticals’s price range in the past 12 months?
Acura Pharmaceuticals lowest stock price was $0.05 and its highest was $0.05 in the past 12 months.
    What is Acura Pharmaceuticals’s market cap?
    Currently, no data Available
    When is Acura Pharmaceuticals’s upcoming earnings report date?
    Acura Pharmaceuticals’s upcoming earnings report date is Nov 14, 2022 which is 500 days ago.
      How were Acura Pharmaceuticals’s earnings last quarter?
      Currently, no data Available
      Is Acura Pharmaceuticals overvalued?
      According to Wall Street analysts Acura Pharmaceuticals’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Acura Pharmaceuticals pay dividends?
        Acura Pharmaceuticals does not currently pay dividends.
        What is Acura Pharmaceuticals’s EPS estimate?
        Acura Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Acura Pharmaceuticals have?
        Acura Pharmaceuticals has 66,001,785 shares outstanding.
          What happened to Acura Pharmaceuticals’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Acura Pharmaceuticals?
          Currently, no hedge funds are holding shares in ACUR
          ---

          Acura Pharmaceuticals Stock Smart Score

          N/A
          Not Ranked
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Company Description

          Acura Pharmaceuticals

          Acura Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of abuse deterrent, orally administered pharmaceutical products. Its technology platforms include AVERSION, IMPEDE, and LIMITX. The company was founded on April 10, 1935 and is headquartered in Palatine, IL.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Talphera
          Achieve Life Sciences
          Aclaris Therapeutics
          Adicet Bio
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis